financetom
Business
financetom
/
Business
/
Sharda Cropchem's CMD discusses the impact of adverse weather on the agrochemical industry
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sharda Cropchem's CMD discusses the impact of adverse weather on the agrochemical industry
Sep 28, 2023 7:44 AM

Adverse weather conditions have long been a concern for the agrochemical sector. The industry is currently grappling with unpredictable weather patterns, which include unseasonal rainfall, extended droughts, and extreme temperature fluctuations. These weather anomalies disrupt agricultural cycles and pose significant challenges to farmers and agrochemical companies alike.

Share Market Live

NSE

Companies like Sharda Cropchem claims to develop new products and solutions that are more resilient in the face of changing weather patterns. These innovations are aiming to help farmers adapt to evolving climate conditions and protect their crops effectively.

In an interview with CNBC-TV18, RV Bubna, the Chairman and Managing Director (CMD) of Sharda Cropchem spoke about the challenges faced by the agrochemical industry due to adverse weather conditions. Bubna's insights offer valuable perspectives on the impact of climate-related factors on agriculture and agrochemical businesses.

One of the primary concerns raised by Bubna is the adverse impact of irregular weather on crop yields. Unpredictable weather conditions can lead to crop failures, reduced crop quality, and decreased agricultural productivity.

Watch:

Rajesh Pherwani, the founder of Valcreate Investment Managers, discussed agrochemical stocks, while Ajit Venkataraman, the Managing Director of Finolex Industries, provided insights into the demand outlook.

For more details, watch the accompanying video.

Also, catch all the updates on markets with CNBC-TV18.com's blog

(Edited by : Sangam Singh)

First Published:Sept 28, 2023 4:44 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Adyen CFO Says US Dual Listing Not Company's Focus At The Moment
BRIEF-Adyen CFO Says US Dual Listing Not Company's Focus At The Moment
May 6, 2026
May 6 (Reuters) - Adyen Chief Financial Officer, Ethan Tandowsky, in interview with Reuters: * DUAL LISTING IN US NOT OUR FOCUS AT THE MOMENT * WE HAVE A VERY INTERNATIONAL INSTITUTIONAL INVESTOR BASE, VERY LONG-TERM ORIENTED INVESTOR BASE * NOT LOOKING TO BUY PAYMENTS INFRASTRUCTURE, GROWING IN INORGANIC WAY IN PAYMENTS NOT THE STRATEGY WE SHOULD TAKE Further company...
Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal
Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal
May 6, 2026
May 6 (Reuters) - Bayer said on Wednesday that it will buy biopharmaceutical company Perfuse Therapeutics to complement its ophthalmology pipeline. The deal has a potential value of up to $2.45 billion, the company said in a statement, with a $300 million upfront payment and additional development, regulatory and commercial milestone payments based on success criteria. The deal will give...
Navitas Semiconductor Q1 Adjusted Loss Narrows, Revenue Declines; Issues Q2 Revenue Guidance
Navitas Semiconductor Q1 Adjusted Loss Narrows, Revenue Declines; Issues Q2 Revenue Guidance
May 6, 2026
03:26 AM EDT, 05/06/2026 (MT Newswires) -- Navitas Semiconductor ( NVTS ) reported a Q1 adjusted loss late Tuesday of $0.04 per diluted share, narrowing from a loss of $0.06 a year earlier. Analysts polled by FactSet expected a non-GAAP loss of $0.05 a share. Revenue for the quarter ended March 31 was $8.6 million, down from $14 million a...
Qualys Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook
Qualys Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook
May 6, 2026
03:18 AM EDT, 05/06/2026 (MT Newswires) -- Qualys ( QLYS ) reported Q1 adjusted earnings late Tuesday of $1.95 per diluted share, up from $1.67 a year earlier. Analysts polled by FactSet expected non-GAAP EPS of $1.80. Revenue for the quarter ended March 31 was $175.6 million, up from $159.9 million a year ago. Analysts surveyed by FactSet expected $173.7...
Copyright 2023-2026 - www.financetom.com All Rights Reserved